2 January 2020

Venner Shipley sponsoring OBN’s BioTuesday ‘Novel Approaches to New Antimicrobials’ in Guildford

Venner Shipley are proud to be sponsoring OBN’s BioTuesday networking event on the 11th February in Guildford; ‘Novel Approaches to New Antimicrobials’.

Antimicrobial resistance is a growing danger to the world’s population, caused predominantly by the overuse of antibiotics in both human health, animal husbandry and agriculture over the past 50 years. AMR is putting more and more lives at risk, with experts warning of a return to a time where everyday infections become life-threatening, with a potential economic cost of over $1 trillion.
Most of our current antibiotics were originally identified from microbes that live in soil, but due to a critical lack of new antibiotics, academics and researchers or ‘BioProspectors’ are looking for solutions via alternative technologies and environmental sources

The growing list of academics, researchers and company leaders will present their latest research and share insight on their vision for the future of antimicrobial research, with the programme currently as follows: 

17:30   Registration & Networking
18:00   Welcome by OBN & Update from Anton Hutter, Partner – Life Sciences, Venner Shipley
18.05   Keynote – Dr Fiona Marston, Director of the Centre of Excellence in Infectious Diseases Research (CEIDR)
18.20   Research Update – Prof. Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases, Deputy Head of School of Veterinary Medicine, University of Surrey
18.35   Research Update – Dr Paul Race, School of Biochemistry, University of Bristol
18.50   Research Update – Dr Piergiorgio Gentile, Lead Author & Biomedical Engineer at Newcastle University
19.05   Company presentation – Prof. Monique Simmonds, Director of Polypharmakos and Deputy Director of Science at the Royal Botanic Gardens Kew
19.20   Company presentation –  Helen Harrison, Group Leader, Bicycle Therapeutics
19.30   Company presentation – Dr Heather Fairhead, CEO at Phico Therapeutics
19.40   Company presentation – David Browning, CEO at Fixed Phage
19.50   Company presentation – Paul Ko Ferrigno, Founder of meta Linear
20.00   Q&A with all speakers
20:30   Networking drinks and nibbles
21:00   Evening ends

For more information and to register to attend, click here.

Event Details

GLIVE,London Road,Guildford,GU1 2AA,GB